Metraipolis › archive › dc_fe4ecebefb3e

In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and… — Europe PMC PMID:39085870

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39085870
DOI
10.1186/s13065-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-08T09:45:32.279Z
SHA-256 of the archived text
0c7410b232d60ef635558d9ff41da5261cf941d1d1fb06b932b676b620a552be
Stable URL of this page
https://metraipolis.com/documento/dc_fe4ecebefb3e

How to cite

In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and… — Europe PMC PMID:39085870 — Europe PMC (en), https://europepmc.org/article/MED/39085870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe4ecebefb3e (Metraipolis archive dc_fe4ecebefb3e, sha256 0c7410b232d60ef635558d9ff41da5261cf941d1d1fb06b932b676b620a552be)
BibTeX
@misc{dcfe4ecebefb3e,
  title = {In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and… — Europe PMC PMID:39085870},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39085870},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe4ecebefb3e; sha256 0c7410b232d60ef635558d9ff41da5261cf941d1d1fb06b932b676b620a552be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39085870. Agents can read the archived copy with the MCP tool read_document.